Bayer stops blood thinner drug trial for lack of effect in major setback, World News - AsiaOne
Por um escritor misterioso
Descrição
Germany's Bayer has aborted a large late-stage trial testing a new anti-clotting drug for lack of efficacy, dealing a fresh blow to the embattled drugmaker and throwing its most promising medium-term development project in doubt. It said in a statement late on Sunday that experimental anticoagulant asundexian, which it had hoped would generate annual sales of more than 5 billion
Pfizer/BioNTech Covid-19 vaccine shows 90.7% efficacy in trial in children, World News - AsiaOne
Germany surpasses 100,000 daily Covid-19 cases for first time, World News - AsiaOne
McLaren boss says F1 budget cap breach amounts to cheating, World News - AsiaOne
Spotify says it will add content advisory to podcasts that discuss Covid-19, Digital News - AsiaOne
Digitrio promises to deliver Faster, Better SEO using the Pareto Principle, Business News - AsiaOne
Asia-Pacific countries begin to ease pandemic-related travel bans, but hurdles remain, World News - AsiaOne
China, Russia conclude drills as US, South Korea, Japan deepen security ties, World News - AsiaOne
Bayer woes pile up as blood thinner drug trial fails
Australian lawmakers call for release of Julian Assange during talks in Washington, World News - AsiaOne
DHL Global Forwarding Asia Pacific certified as Top Employer 2022 third time in a row, Business News - AsiaOne
Messi says he struggled to adapt after PSG move, some fans treated him differently, World News - AsiaOne
US FTC argues Microsoft's deal to buy Activision should be paused, Money News - AsiaOne
Blood Thinners Recalled Over Cancer-Causing Impurity
de
por adulto (o preço varia de acordo com o tamanho do grupo)
